Cervical Cancer Prevention with HPV Vaccines

Authors

  • Chaivanee Kaosayapandhu

Keywords:

Cervical cancer, Human Papillomavirus (HPV), Pap smear, HPV Vaccine, Bivalent vaccine, Quadri- valent vaccine

Abstract

Cervical cancer is the most common malignancy in Thai women with 70% of all cases caused by Human Papillomavirus (HPV) 16, 18 and transmitted by sexual intercourse. Cervical cancer can be prevented by screening tests and HPV vaccines. In Thailand HPV vaccines currently are available in 2 types which are Bivalent, which has HPV 16,18 antigen and AS04 immunizer resulting in high immunization, and Quadrivalent, which has HPV 16,18 antigen and HPV 6,11 antigen which are not the cause of cervical cancer but of genital warts. The result of the study shows the differences of both types of vaccines in immunization mechanism, efficacy, cross-link prevention and indications. Both vaccines are certified for their safety. No severe side effects are found. Mild frequent side effects such as swelling, aching, redness will resolve spontaneously. HPV vaccines are most useful in female adolescents. However, women over 26 years of age or those who have sexual intercourse still benefit from vaccination especially when combined with annual Pap smear screening.

 

Downloads

Published

06-04-2017

How to Cite

Kaosayapandhu, C. (2017). Cervical Cancer Prevention with HPV Vaccines. Siriraj Medical Journal, 65(5), 149–152. Retrieved from https://he02.tci-thaijo.org/index.php/sirirajmedj/article/view/82342

Issue

Vol. 65 No. 5 (2013): September-October

Section

Review Article

License

Authors who publish with this journal agree to the following conditions:

Copyright Transfer

In submitting a manuscript, the authors acknowledge that the work will become the copyrighted property of Siriraj Medical Journal upon publication.

License

 Articles are licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0). This license allows for the sharing of the work for non-commercial purposes with proper attribution to the authors and the journal. However, it does not permit modifications or the creation of derivative works.

Sharing and Access

Authors are encouraged to share their article on their personal or institutional websites and through other non-commercial platforms. Doing so can increase readership and citations.